Ta Dah!
 

2005

Professor Griffiths, Foundation Professor of Dermatology at The University of Manchester, in the UK, began research on No7 Protect & Perfect Serum, using a 12-day patch-test trial that he had developed while working at the University of Michigan. He was a sceptic about the idea that cosmetic anti-ageing products might genuinely improve the skin, but researchers put No7 Protect & Perfect Serum to the test against trans-retinoic acid, the gold-standard, prescription-only treatment for reducing wrinkling in the skin. His results showed that No7 Protect & Perfect Serum improved aspects of photo-aged skin in a similar way to trans-retinoic acid; the first time that the performance of a cosmetic product had been demonstrated in this way.

2007

When this research was reported on a BBC Horizon programme in March, the reaction was instant and unprecedented, prompting a significant sales increase overnight on boots.com and across Boots stores in the following weeks.

2008

In March the full research was published in the British Journal of Dermatology.

2009

No7 Protect & Perfect Intense Serum was also found to have genuine, long-term anti-ageing benefits in a further 12 -month clinical trial also conducted at The University of Manchester. The serum, which targets deeper lines and wrinkles, and which is aimed at the 35-45 year old customer, was found to promote structural repair in the skin. This change was demonstrated by observing the changes in the levels of fibrillin, a protein that plays a key role in keeping the skin firm and elastic. The fibrillin repair was associated with a clinical reduction in the appearance of wrinkles. This study proved to be another landmark for No7, putting a cosmetic product into blind testing for a year. Again, this research was published in the British Journal of Dermatology, in August 2009.

2012

The experts at No7 developed a third, clinically proven serum, No7 Lift & Luminate Day & Night Serum, proven to tackle the three key signs of ageing in women aged 45 - 60, namely lines and wrinkles, the loss of firmness, and uneven skin tone such as age spots. This product put together the existing, well -proven ingredients from the No7 Protect & Perfect formula with new de-pigmentation actives in revolutionary new separate day and night formulations. A pioneering clinical trial was undertaken by one of the world’s leading experts in pigmentation, Professor Ortonne, Head of Dermatology, Hopital L’Archet in Nice. The serums were tested against 4% Hydroquinone, commonly regarded by dermatologists as the gold-standard topical treatment for hyper-pigmentation, and the trial provided clinical proof that the serum had the ability to lighten and shrink age spots.

Professor Ortonne commented: "The results are exceptional - better than any other cosmetic product I have tested for the fading of age spots, with similar performance to the gold standard prescription-only treatment after four months use."

“Extensive research has enabled us to develop this clinically proven serum, which works at a deeper level to restore youthful skin for women aged 60 and over. In addition to wrinkles, loss of firmness and uneven skin tone, post-menopausal skin can become persistently drier and less resilient and lack luminosity due to the decline in oestrogen levels. Our unique complexes and proven technologies combined with a highly effective No7 serum delivery system help tackle each of these issues head-on, leaving skin feeling and looking younger in just four weeks.”

Dr Mike Bell
Boots Skincare Scientific Advisor

 
Copyright © The Boots Company PLC. All rights reserved. Registered office: Nottingham NG2 3AA. Registered in England and Wales: company number 00027657. Registered VAT number 116300129. "No7", "Protect & Perfect Advanced", "Protect & Perfect Intense Advanced", "Protect & Perfect", "Protect & Perfect Intense", "Lift & Luminate", "Restore & Renew" are trademarks of The Boots Company PLC.